The coronavirus E protein: assembly and beyond. Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus. Available from: īrison E, Jacomy H, Desforges M, Talbot PJ. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically-Proven Protease Inhibitor. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S. Commentary Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Advice on the use of masks in the community, during home care and in healthcare settings in the context of the novel coronavirus (2019-nCoV) outbreak. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.
COVID 19 ORIGIN SKIN
Consensus of Chinese experts on protection of skin and mucous membrane barrier for healthcare workers fighting against coronavirus disease 2019. Yan Y, Chen H, Chen L, Cheng B, Diao P, et al. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Available from: Ĭonforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I. Origin and evolution of pathogenic coronaviruses. Antigen production in plant to tackle infectious diseases flare up: the case of SARS. Available from:ĭemurtas OC, Massa S, Illiano E, Martinis DD, Chan PKS, Bonito PD, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Available from: īanerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. The economic impact of SARS: how does the reality match the predictions? Health Policy. Emerging coronaviruses: genome structure, replication, and pathogenesis. A new virus isolated from the human respiratory tract. MERS, SARS and other coronaviruses as causes of pneumonia.
Coronaviruses as encephalitis-inducing infectious agents. Talbot PJ, Desforges M, Brison E, Jacomy H. An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Vabret A, Mourez T, Gouarin S, Petitjean J, Freymuth F. Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Lana RM, Coelho FC, Gomes MFC, Cruz OG, Bastos, LS, Villela, DAM, et al. Responding to COVID-19: The UW medicine information technology services experience. Grange ES, Neil EJ, Stoffel M, Singh AP, Tseng E, Resco-Summers K, et al. WHO hedges its bets: the next global pandemic could be disease X. Influenza virus-related critical illness: prevention, diagnosis, treatment. Available from: Ĭhow EJ, Doyle JD, Uyeki TM. Genomic epidemiology and its importance in the study of the COVID-19 pandemic. Rodriguez-Morales AJ, Balbin-Ramon GJ, Rabaan AA, Sah R, Dhama K, Paniz Mondolfi A, et al. Molecular characteristics, functions, and related pathogenicity of MERS-CoV proteins. Currently, controlling the infection is the best way to prevent the spread of the novel coronavirus. Conclusion: Various studies are underway to identify potential treatments for COVID-19. Given these facts, countless countries have adopted extensive control measures to reduce the transmission of the disease from person to person. Implications: COVID-19 is highly pathogenic, and no specific treatment or vaccine is currently available. Outline: This is a narrative review, in which searches were carried out for articles in the PubMed and Science Direct databases. The objective is to inform about COVID-19, highlighting its history, genomic organization of the novel coronavirus, pathogenesis, diagnosis, clinical manifestations, transmission, control, prevention and current therapeutic strategies. Introduction: In December 2019, the novel 2019 coronavirus disease (COVID-19) in China caused a global outbreak and is a major public health problem and the World Health Organization declared that COVID-19 constituted an International Public Health Emergency.
0 kommentar(er)
